Enterococcal bloodstream infection. Design and validation of a mortality prediction rule

International Journal of Clinical Practice
A Pérez-GarcíaJ L Del Pozo

Abstract

To develop a prediction rule to describe the risk of death as a result of enterococcal bloodstream infection. A prediction rule was developed by analysing data collected from 122 patients diagnosed with enterococcal BSI admitted to the Clínica Universidad de Navarra (Pamplona, Spain); and validated by confirming its accuracy with the data of an external population (Hospital del Mar, Barcelona). According to this model, independent significant predictors for the risk of death were being diabetic, have received appropriate treatment, severe prognosis of the underlying diseases, have renal failure, received solid organ transplant, malignancy, source of the bloodstream infection and be immunosuppressed. The prediction rule showed a very good calibration (Hosmer-Lemeshow statistic, P = 0.93) and discrimination for both training and testing sets (area under ROC curve = 0.84 and 0.83 respectively). The predictive rule was able to predict risk of death as a result of enterococcal bloodstream infection as well as to identify patients, who being below the threshold value, will have a low risk of death with a negative predictive value of 96%.

References

Jan 1, 1990·Clinical Microbiology Reviews·B E Murray
Dec 1, 1989·American Journal of Infection Control·S L LandryR P Wenzel
Nov 1, 1994·Journal of Clinical Epidemiology·M CharlsonJ Gold
Mar 21, 1998·Emerging Infectious Diseases·B E Murray
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F J Caballero-GranadoJ Pachón
Apr 18, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F J Caballero-GranadoJ Pachón
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K C ReidR Patel
Oct 3, 2002·The Journal of Antimicrobial Chemotherapy·Jonathan A T SandoeMark H Wilcox
Aug 14, 2003·JAMA : the Journal of the American Medical Association·Charles L SprungUNKNOWN Ethicus Study Group
Apr 24, 2004·Intensive Care Medicine·Kalina GajewskaJean-Louis Vincent
Jan 12, 2007·The Journal of Clinical Hypertension·Murray Epstein
Aug 8, 2007·International Journal of Antimicrobial Agents·Evelina TacconelliRoberto Cauda
Oct 5, 2007·Enfermedades infecciosas y microbiología clínica·Pedro Martínez-OdriozolaFelipe Miguel de la Villa
Nov 20, 2008·Annals of Internal Medicine·Holly JanesWen Gu
Dec 17, 2008·American Journal of Infection Control·Cassandra D Salgado
May 30, 2009·Enfermedades infecciosas y microbiología clínica·Francisco Javier Martínez-MarcosUNKNOWN Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas
Sep 29, 2009·Enfermedades infecciosas y microbiología clínica·David Conde-EstévezSantiago Grau
Nov 17, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S J McBrideS A Roberts
Jun 24, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I G SavaJ Huebner
Aug 17, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D Conde-EstévezH Knobel
Oct 12, 2010·Lancet·J Randall Curtis, Jean-Louis Vincent
Oct 16, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M SuppliJ-U S Jensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.